These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 12759801

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D, Frokjaer VG, Holst KK, Christoffersen M, Johansen SS, Svarer C, Madsen J, Rasmussen PM, Ramsøy T, Jernigan TL, Knudsen GM.
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.
    Reneman L, Booij J, Schmand B, van den Brink W, Gunning B.
    Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746
    [Abstract] [Full Text] [Related]

  • 65. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA, Wetherell MA, Fisk JE, Montgomery C.
    Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
    [Abstract] [Full Text] [Related]

  • 68. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
    Garg A, Kapoor S, Goel M, Chopra S, Chopra M, Kapoor A, McCann UD, Behera C.
    Curr Drug Abuse Rev; 2015 Oct; 8(1):15-25. PubMed ID: 25731754
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
    Potter A, Downey L, Stough C.
    Curr Drug Abuse Rev; 2013 Mar; 6(1):71-6. PubMed ID: 23259912
    [Abstract] [Full Text] [Related]

  • 77. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
    Hanson KL, Luciana M.
    Psychol Med; 2004 Feb; 34(2):229-46. PubMed ID: 14982129
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 80. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
    Curran HV, Travill RA.
    Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.